Skip to main content
. Author manuscript; available in PMC: 2020 Aug 10.
Published in final edited form as: Clin Exp Metastasis. 2011 Sep 21;28(8):899–908. doi: 10.1007/s10585-011-9421-9

Fig. 3.

Fig. 3

p53 immunoreactivity on a tissue microarray of matched resected primary breast tumors and brain metastases. a Graph represents the magnitude of increase in immunoreactivity between a primary tumor and the matched brain metastatic lesion. Grey (squares) show patient matched samples with the greatest increase from low primary tumor expression to high brain metastasis expression. b Representative images of low staining in a primary tumor sample and high staining in the corresponding brain metastasis sample